MacLachlan, Ian
Arbutus Biopharma Corporation,
Canada
2025 Rank: 231997
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 780 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 231997 | 258910 |
| Total Cites | 9759 | 10300 |
| H-index | 31 | 32 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 59 | 60 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 112 | 123 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 6086 | 6330 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6420 | 6616 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.56 |
| Self-Citation Percentage |
5.25%
|
|
MacLachlan, Ian
Arbutus Biopharma Corporation,
Canada
2024 Rank: 226120
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 743 out of 62673 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 226120 | 247922 |
| Total Cites | 9196 | 9727 |
| H-index | 30 | 32 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 56 | 57 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 107 | 118 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 5776 | 6016 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6026 | 6216 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.56 |
| Self-Citation Percentage |
5.46%
|
|
MacLachlan, Ian
Arbutus Biopharma Corporation,
Canada
2023 Rank: 213542
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 684 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 213542 | 234486 |
| Total Cites | 8738 | 9253 |
| H-index | 30 | 32 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 55 | 56 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 104 | 115 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 5532 | 5767 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5698 | 5877 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.57 |
| Self-Citation Percentage |
5.57%
|
|
MacLachlan, Ian
Arbutus Biopharma Corporation,
Canada
2022 Rank: 210158
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 666 out of 56174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 210158 | 227587 |
| Total Cites | 8116 | 8615 |
| H-index | 29 | 32 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 47 | 48 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 92 | 103 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 5171 | 5404 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5283 | 5454 |
| Ratio of Total Citations to Distinct Citing Papers | 1.54 | 1.58 |
| Self-Citation Percentage |
5.79%
|
|
Related Profiles
.jpg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.